Acenocoumarol or warfarin: Which is the clinician’s ally?

N. Karthik Rao, Navin Patil, A. Avinash, Handattu Manjunatha Hande, Sushil Kiran Kunder, N. Raghavendra Rao

Research output: Contribution to journalArticle

Abstract

Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.

Original languageEnglish
Pages (from-to)4-5
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume9
Issue number2
Publication statusPublished - 01-03-2016

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Acenocoumarol or warfarin: Which is the clinician’s ally?'. Together they form a unique fingerprint.

  • Cite this

    Karthik Rao, N., Patil, N., Avinash, A., Hande, H. M., Kunder, S. K., & Raghavendra Rao, N. (2016). Acenocoumarol or warfarin: Which is the clinician’s ally? Asian Journal of Pharmaceutical and Clinical Research, 9(2), 4-5.